- Home
- CRVS vs BRBS Comparison
CRVS vs BRBS Comparison
Compare CRVS & BRBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRVS
- BRBS
- Stock Information
- Founded
- CRVS 2014
- BRBS 1893
- Country
- CRVS United States
- BRBS United States
- Employees
- CRVS N/A
- BRBS N/A
- Industry
- CRVS Biotechnology: Pharmaceutical Preparations
- BRBS Commercial Banks
- Sector
- CRVS Health Care
- BRBS Finance
- Exchange
- CRVS Nasdaq
- BRBS Nasdaq
- Market Cap
- CRVS 305.4M
- BRBS 326.4M
- IPO Year
- CRVS 2016
- BRBS N/A
- Fundamental
- Price
- CRVS $5.75
- BRBS $4.02
- Analyst Decision
- CRVS Strong Buy
- BRBS
- Analyst Count
- CRVS 4
- BRBS 0
- Target Price
- CRVS $15.00
- BRBS N/A
- AVG Volume (30 Days)
- CRVS 518.7K
- BRBS 444.7K
- Earning Date
- CRVS 08-07-2025
- BRBS 10-28-2025
- Dividend Yield
- CRVS N/A
- BRBS N/A
- EPS Growth
- CRVS N/A
- BRBS N/A
- EPS
- CRVS N/A
- BRBS N/A
- Revenue
- CRVS N/A
- BRBS $96,787,000.00
- Revenue This Year
- CRVS N/A
- BRBS N/A
- Revenue Next Year
- CRVS N/A
- BRBS N/A
- P/E Ratio
- CRVS N/A
- BRBS N/A
- Revenue Growth
- CRVS N/A
- BRBS 10.13
- 52 Week Low
- CRVS $2.54
- BRBS $2.66
- 52 Week High
- CRVS $10.00
- BRBS $4.14
- Technical
- Relative Strength Index (RSI)
- CRVS 65.10
- BRBS 63.43
- Support Level
- CRVS $5.28
- BRBS $3.63
- Resistance Level
- CRVS $5.64
- BRBS $4.14
- Average True Range (ATR)
- CRVS 0.30
- BRBS 0.12
- MACD
- CRVS 0.03
- BRBS 0.03
- Stochastic Oscillator
- CRVS 77.70
- BRBS 75.49
About CRVS Corvus Pharmaceuticals Inc.
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).
About BRBS Blue Ridge Bankshares Inc.
Blue Ridge Bankshares Inc is a United States-based company engaged in offering commercial and consumer banking and financial services through its wholly-owned bank subsidiary, Blue Ridge Bank, National Association, and its non-bank financial services affiliates. The bank offers services such as checking accounts, savings accounts, money market accounts, cash management accounts, commercial and industrial loans, residential mortgages, commercial mortgages, home equity loans, consumer installment loans, investment accounts, insurance and others. It has three reportable business segments: commercial banking, mortgage banking, and holding company activities.